295 related articles for article (PubMed ID: 37630602)
1. Could the Urease of the Gut Bacterium
Grahl MVC; Andrade BDS; Perin APA; Neves GA; Duarte LS; Uberti AF; Hohl KS; Follmer C; Carlini CR
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630602
[TBL] [Abstract][Full Text] [Related]
2.
Grahl MVC; Uberti AF; Broll V; Bacaicoa-Caruso P; Meirelles EF; Carlini CR
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281258
[TBL] [Abstract][Full Text] [Related]
3. 6-Shogaol, an Active Ingredient of Ginger, Improves Intestinal and Brain Abnormalities in
Huh E; Choi JG; Choi Y; Ju IG; Noh D; Shin DY; Kim DH; Park HJ; Oh MS
Biomol Ther (Seoul); 2023 Jul; 31(4):417-424. PubMed ID: 37337830
[TBL] [Abstract][Full Text] [Related]
4. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
5. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
8. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
[TBL] [Abstract][Full Text] [Related]
9. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.
Liang F; Chen CY; Li YP; Ke YC; Ho EP; Jeng CF; Lin CH; Chen SK
J Parkinsons Dis; 2022; 12(8):2423-2440. PubMed ID: 36155528
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota.
Zhang Y; Xu S; Qian Y; Mo C; Ai P; Yang X; Xiao Q
Front Aging Neurosci; 2023; 15():1099018. PubMed ID: 36761177
[TBL] [Abstract][Full Text] [Related]
11. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
12. P. mirabilis-derived pore-forming haemolysin, HpmA drives intestinal alpha-synuclein aggregation in a mouse model of neurodegeneration.
Huh E; Choi JG; Choi Y; Ju IG; Kim B; Shin YJ; An JM; Park MG; Yim SV; Chung SJ; Seo SU; Kim D; Kim CH; Kim DH; Oh MS
EBioMedicine; 2023 Dec; 98():104887. PubMed ID: 37995468
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter hepaticus augmentation triggers Dopaminergic degeneration and motor disorders in mice with Parkinson's disease.
Ahn EH; Liu X; Alam AM; Kang SS; Ye K
Mol Psychiatry; 2023 Mar; 28(3):1337-1350. PubMed ID: 36543925
[TBL] [Abstract][Full Text] [Related]
14. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease.
Drobny A; Ngo PA; Neurath MF; Zunke F; López-Posadas R
Front Med (Lausanne); 2021; 8():655123. PubMed ID: 34368179
[TBL] [Abstract][Full Text] [Related]
15. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory gut as a pathologic and therapeutic target in Parkinson's disease.
Lee JY; Wang ZJ; Moscatello A; Kingsbury C; Cozene B; Farooq J; Saft M; Sadanandan N; Gonzales-Portillo B; Zhang H; Salazar FE; Toledo ARL; Monroy GR; Berlet R; Sanberg CD; Sanberg PR; Borlongan CV
Cell Death Discov; 2022 Sep; 8(1):396. PubMed ID: 36153318
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary study on time-dependent changes of intestinal tract and brain-gut axis in mice model of Parkinson's disease induced by paraquat].
Wang KD; Zhang BY; Zhang BF; Huang M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Mar; 40(3):161-169. PubMed ID: 35439855
[No Abstract] [Full Text] [Related]
18. [Effects of Nardostachys jatamansi on gut microbiota of rats with Parkinson's disease].
Wan GH; Wei XJ; Li JY; Yang X; Yu JH; Liu JF; Wang YQ; Lyu Y; Jin ZX; Shi JL
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):499-510. PubMed ID: 35178995
[TBL] [Abstract][Full Text] [Related]
19. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
20. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
